Tissue Regenix Group plc TRX.L Stock
Tissue Regenix Group plc Price Chart
Tissue Regenix Group plc TRX.L Financial and Trading Overview
Tissue Regenix Group plc stock price | 61.5 GBP |
Previous Close | 55.5 GBP |
Open | 55 GBP |
Bid | 55 GBP x 0 |
Ask | 56 GBP x 0 |
Day's Range | 55 - 55.45 GBP |
52 Week Range | 40.9 - 71 GBP |
Volume | 10.35K GBP |
Avg. Volume | 79.62K GBP |
Market Cap | 39.01M GBP |
Beta (5Y Monthly) | 1.511494 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 120 GBP |
TRX.L Valuation Measures
Enterprise Value | 41.42M GBP |
Trailing P/E | N/A |
Forward P/E | 1.109 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.5939497 |
Price/Book (mrq) | 124.60674 |
Enterprise Value/Revenue | 1.692 |
Enterprise Value/EBITDA | -39.862 |
Trading Information
Tissue Regenix Group plc Stock Price History
Beta (5Y Monthly) | 1.511494 |
52-Week Change | 27.90% |
S&P500 52-Week Change | 20.43% |
52 Week High | 71 GBP |
52 Week Low | 40.9 GBP |
50-Day Moving Average | 55.52 GBP |
200-Day Moving Average | 57.66 GBP |
TRX.L Share Statistics
Avg. Volume (3 month) | 79.62K GBP |
Avg. Daily Volume (10-Days) | 35.43K GBP |
Shares Outstanding | 70.36M |
Float | 38.62M |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -11.010% |
Operating Margin (ttm) | -8.21% |
Gross Margin | 45.99% |
EBITDA Margin | -4.24% |
Management Effectiveness
Return on Assets (ttm) | -2.72% |
Return on Equity (ttm) | -8.13% |
Income Statement
Revenue (ttm) | 24.48M GBP |
Revenue Per Share (ttm) | 0.35 GBP |
Quarterly Revenue Growth (yoy) | 22.60% |
Gross Profit (ttm) | 11.26M GBP |
EBITDA | -1039000 GBP |
Net Income Avi to Common (ttm) | -2695000 GBP |
Diluted EPS (ttm) | -0.03 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 5.95M GBP |
Total Cash Per Share (mrq) | 0.09 GBP |
Total Debt (mrq) | 9.61M GBP |
Total Debt/Equity (mrq) | 31.6 GBP |
Current Ratio (mrq) | 3.317 |
Book Value Per Share (mrq) | 0.445 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1294000 GBP |
Levered Free Cash Flow (ttm) | -1859500 GBP |
Profile of Tissue Regenix Group plc
Country | United Kingdom |
State | N/A |
City | Garforth |
Address | Phoenix Court |
ZIP | LS25 2GY |
Phone | 44 33 0430 3052 |
Website | https://www.tissueregenix.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 85 |
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. It operates in three segments: dCELL, BioRinse, and GBM-V. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. It also offers DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, a decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. In addition, it provides OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Further, the company offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom.
Q&A For Tissue Regenix Group plc Stock
What is a current TRX.L stock price?
Tissue Regenix Group plc TRX.L stock price today per share is 61.5 GBP.
How to purchase Tissue Regenix Group plc stock?
You can buy TRX.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tissue Regenix Group plc?
The stock symbol or ticker of Tissue Regenix Group plc is TRX.L.
Which industry does the Tissue Regenix Group plc company belong to?
The Tissue Regenix Group plc industry is Biotechnology.
How many shares does Tissue Regenix Group plc have in circulation?
The max supply of Tissue Regenix Group plc shares is 705.74K.
What is Tissue Regenix Group plc Price to Earnings Ratio (PE Ratio)?
Tissue Regenix Group plc PE Ratio is now.
What was Tissue Regenix Group plc earnings per share over the trailing 12 months (TTM)?
Tissue Regenix Group plc EPS is -0.02 GBP over the trailing 12 months.
Which sector does the Tissue Regenix Group plc company belong to?
The Tissue Regenix Group plc sector is Healthcare.
Tissue Regenix Group plc TRX.L included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}